Two Sigma Advisers’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-62,125
Closed -$502K 2983
2022
Q1
$502K Buy
62,125
+2,095
+3% +$21.4K ﹤0.01% 1985
2021
Q4
$799K Buy
60,030
+55,795
+1,317% +$1.4M ﹤0.01% 1680
2021
Q3
$185K Buy
4,235
+325
+8% +$14K ﹤0.01% 2264
2021
Q2
$163K Sell
3,910
-8,315
-68% -$365K ﹤0.01% 2292
2021
Q1
$592K Sell
12,225
-9,190
-43% -$535K ﹤0.01% 1943
2020
Q4
$2.1M Sell
21,415
-6,165
-22% -$540K 0.01% 1233
2020
Q3
$1.9M Buy
27,580
+7,085
+35% +$618K 0.01% 1188
2020
Q2
$2.16M Buy
20,495
+6,010
+41% +$714K 0.01% 1167
2020
Q1
$1.29M Buy
14,485
+3,815
+36% +$454K ﹤0.01% 1345
2019
Q4
$1.22M Buy
10,670
+2,640
+33% +$199K ﹤0.01% 1480
2019
Q3
$496K Buy
8,030
+4,960
+162% +$397K ﹤0.01% 1718
2019
Q2
$239K Buy
3,070
+1,440
+88% +$163K ﹤0.01% 2085
2019
Q1
$220K Buy
1,630
+805
+98% +$84.6K ﹤0.01% 2093
2018
Q4
$66K Buy
+825
New +$81.4K ﹤0.01% 2261
2018
Q1
Sell
-515
Closed -$86K 2461
2017
Q4
$86K Buy
+515
New +$132K ﹤0.01% 2162

Other funds holding CALA

Two Sigma Advisers's CALA Position: Q2 2022 in Review

Two Sigma Advisers sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 62,125 shares — an estimated $502K sold.

Two Sigma Advisers first reported a position in CALA in Q4 2017 and held it in 15 quarters. The position peaked at $2.16M in Q2 2020. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Two Sigma Advisers reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 62,125 Calithera Biosciences, Inc shares in Q2 2022, an estimated $502K.
  • Two Sigma Advisers first reported a position in Calithera Biosciences, Inc in Q4 2017 and held it in 15 quarters.
  • Two Sigma Advisers's Calithera Biosciences, Inc position peaked at $2.16M in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.